Skip to main content
Log in

Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Intermittent maple syrup urine disease (MSUD) is a potentially life-threatening metabolic disorder caused by a deficiency of branched chain α-ketoacid dehydrogenase (BCKD) complex. In contrast to classic MSUD, children with the intermittent form usually have an atypical clinical manifestation. Here, we describe the presenting symptoms and clinical course of a Chinese boy with intermittent MSUD. Mutation analysis identified two previously unreported mutations in exon 7 of the BCKDHB gene: c.767A > G (p.Y256C) and c.768C > G (p.Y256X); the parents were each heterozygous for one of these mutations. In silico analysis predicted Y256C probably affects protein structure; Y256X leads to a premature stop codon. This case demonstrates intermittent MSUD should be suspected in cases with symptoms of recurrent encephalopathy, especially ataxia or marked drowsiness, which usually present after the neonatal period and in conjunction with infection. symmetrical basal ganglia damage but normal myelination in the posterior limb will assist differential diagnosis; alloisoleucine is a useful diagnostic marker and mutation analysis may be of prognostic value. These novel mutations Y256C and Y256X result in the clinical manifestation of a variant form of MSUD, expanding the mutation spectrum of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Axler O, Holmquist P (2014) Intermittent maple syrup urine disease: two case reports. Pediatrics 133(2):e458–60

    Article  PubMed  Google Scholar 

  • Bindu PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S (2007) Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India. J Child Neurol 22(7):911–3

    Article  CAS  PubMed  Google Scholar 

  • Bindu PS, Kovoor JM, Christopher R (2010) Teaching NeuroImages: MRI in maple syrup urine disease. Neurology 74(3):516–524

    Article  Google Scholar 

  • Hou JW, Hwang TL (2014) Different gene preferences of maple syrup urine disease in the aboriginal tribes of Taiwan. Pediatr Neonatol 55(3):213–7

    Article  PubMed  Google Scholar 

  • Jaafar N, Moleirinho A, Kerkeni E et al (2013) Molecular characterization of maple syrup urine disease patients from Tunisia. Gene 517(1):116–119

    Article  CAS  PubMed  Google Scholar 

  • Kilicarslan R, Alkan A, Demirkol D et al (2012) Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol 30(6):522–525

    Article  PubMed  Google Scholar 

  • Schadewaldt P, Bodner-Leidecker A, Hammen HW et al (1999) Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem 45(10):1734–1740

    CAS  PubMed  Google Scholar 

  • Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341

    Article  PubMed  Google Scholar 

  • Strauss KA, Puffenberger EG, Morton DH (1993) Maple syrup urine disease. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) eneReviews™. University of Washington, Seattle

    Google Scholar 

  • Wang YP, Qi ML, Li TT, Zhao YJ (2012) Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). Gene 498(1):112–5

    Article  CAS  PubMed  Google Scholar 

  • Wynn RM, Machius M, Chuang JL, Li J, Tomchick DR, Chuang DT (2003) Roles of His291-αand His146-βin the reductive acylation reaction catalyzed by human ranched-chain α-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site. J Biol Chem 278:43402–43410

    Article  CAS  PubMed  Google Scholar 

  • Yang N, Han L, Gu X et al (2012) Analysis of gene mutations in Chinese patients with maple syrup urine disease. Mol Genet Metab 106(4):412–418

    Article  CAS  PubMed  Google Scholar 

  • Zhao Y, Hawes J, Popov KM, Jaskiewicz J, Shimomura Y, Crabb DW, Harris RA (1994) Site-directed mutagenesis of phosphorylation sites of the branched chainα-ketoacid ehydrogenase complex. J Biol Chem 269:18583–18587

    CAS  PubMed  Google Scholar 

  • Zinnanti WJ, Lazovic J, Griffin K et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132(4):903–918

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi Guo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, Y., Liming, L. & Jiang, L. Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease. Metab Brain Dis 30, 1395–1400 (2015). https://doi.org/10.1007/s11011-015-9711-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-015-9711-z

Keywords

Navigation